Prescription Opioid Abuse and Dependence Usoa E. Busto, Pharm.D. Beth Sproule, Pharm. D. Bruna Brands, Ph.D. Centre for Addiction and Mental Health October.

Slides:



Advertisements
Similar presentations
The Who Behind Pharmaceutical Misuse and Abuse – What We Know About Pharmaceutical Abusers Linda Simoni-Wastila, PhD Associate Professor University of.
Advertisements

Substance Related Disorders
Welcome to the Open Sky Webinar! We will start at 6pm- see you soon.
DSM – 5 Substance-Related and Addictive Disorders
Prevalence and Patterns of Nonmedical Use of OxyContin ® and Other Pain Relievers Joe Gfroerer Office of Applied Studies Substance Abuse and Mental Health.
® Introduction Low Back Pain and Physical Function Among Different Ethnicities Adelle A Safo, Sarah Holder DO, Sandra Burge PhD The University of Texas.
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Sublingual Buprenorphine and Pain
Results from the 2006 National Survey on Drug Use and Health (NSDUH) Briefing for DHHS, September 5, 2007 Joe Gfroerer Office of Applied Studies Substance.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2009.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May-June 2007.
Prescription Drug Abuse and Misuse in the Elderly Thomas L. Patterson, Ph.D. Support for this work: NIMH Center Grants P30 MH49693 and MH45131, and by.
1 Prescription Drug Nonmedical Use and Abuse in Older Women Drug abuse in the 21 st century: what lies ahead for the baby boomers? Linda Simoni-Wastila,
SBIRT Module 2: Screening for Substance Use Problems in Primary Care UCSF SBIRT Collaborative Education Project Janice Tsoh, PhD.
® Introduction Mental Health Predictors of Pain and Function in Patients with Chronic Low Back Pain Olivia D. Lara, K. Ashok Kumar MD FRCS Sandra Burge,
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Diagnosis And Treatment Of Prescription Opioid Dependence Steven W. Clay, D.O. Associate Professor, Department of Family Medicine Ohio University College.
LEGAL AND ILLEGAL SUBSTANCES. LEGAL DRUGS Legal drugs are considered permissible for use, and are either prescribed by a physician (prescription medications)
Causes and Treatment of Substance Use Disorders Chapter 11.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
Aberrant Drug-taking Behaviors in Medically Ill Pain Patients Aberrant Drug-taking Behaviors in Medically Ill Pain Patients Steven D. Passik, PhD Director,
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Assessment of Substance Use Disorders
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
Substance Use Disorders: Overview Chapter 10 Perspectives on Substance-Related Disorders: An Overview The Nature of Substance-Related Disorders Problems.
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module III – Buprenorphine 101.
Characteristics of Patients Using Extreme Opioid Dosages in the Treatment of Chronic Low Back Pain In this sample of 204 participants, 70% were female,
® From Bad to Worse: Comorbidities and Chronic Lower Back Pain Margaret Cecere JD, Richard Young MD, Sandra Burge PhD The University of Texas Health Science.
Substance use General Unless otherwise indicated, all answers are from DSM-IV-TR or from Practice Guideline, AJP, Supplement, August 2006 As of 6Sep08.
Concerns About Addiction: Bringing Clarity to Confusion about Addiction Terminology Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
For Pain or Not for Pain: Methadone Madness
From the Monitoring the Future Study Report: The University of Michigan 2012.
Chapter 1: Introduction to Drug Use & Abuse PSY 302: Substance Abuse.
Procedural Interventions And Chronic Low Back Pain: Changes Over One Year This sample included 137 patients with complete surveys and chart reviews; 74%
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Opiates. Opiates: what, exactly are they?!? Opiates are used to induce sleep and alleviate pain. They act as depressants to the central nervous system.
DRUGS OF ABUSE Reynaldo J. Lesaca, M.D. Reynaldo J. Lesaca, M.D.
TRI science addiction Profiles of OxyContin Users Deni Carise, PH.D. Treatment Research Institute, University of Pennsylvania San Antonio, TX. October,
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
Defining substance abuse Health Psychology. Introduction to Substances.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
® Changes in Opioid Use Over One Year in Patients with Chronic Low Back Pain Alejandra Garza, Gerald Kizerian, PhD, Sandra Burge, PhD The University of.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
Jennifer R. Havens, PhD, MPH Associate Professor
Clinical Trial Finds That While Buprenorphine-Naloxone Maintenance Reduced Other Opioid Use Among Those Dependent on Prescription Opioids, 91% Were Not.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
M. Fe Caces, Ph.D. Office of National Drug Control Policy Executive Office of the President September 2004 Gender Differences in Drug Treatment Data in.
Substance Abuse Spring Substance-Related Disorders Substance abuse Substance dependence –Tolerance –Withdrawal Substance intoxication 2 Define substance.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
A comprehensive evaluation of post- mortem findings and psychiatric case records of individuals who died by probable suicide. A van Laar, J Kielty, M Davoren,
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
Methadone and Suboxone
A systematic review of the relationship between substance abuse and psychotropic medication adherence: opportunities to improve outcomes for patients with.
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Substance Use Disorders
Assessing Opioid Use Disorder, part 1
Diagnosis and Recognition of OUD
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Office of Aerospace. Medicine
Opiate misuse among our seniors
Presentation transcript:

Prescription Opioid Abuse and Dependence Usoa E. Busto, Pharm.D. Beth Sproule, Pharm. D. Bruna Brands, Ph.D. Centre for Addiction and Mental Health October 18, 2004

Prescription Opioids Prescription opioids are widely used for pain management and bring important improvements in quality of life However most opioid medications have a potential to be abused and cause dependence e.g. morphine, hydromorphone, oxycodone, hydrocodone, and codeine

Prescription Opioids The challenge is to balance the need to make psychotropic medications readily available for therapeutic use while minimizing the risk of their abuse.

Annual Numbers of New Nonmedical Users of Psychotherapeutics: Thousands of New Users Pain Relievers Tranquilizers Stimulants Sedatives Source: National Survey on Drug Abuse, 2001

Narcotic Painkiller Admissions, by Age: 1997 and Age of Admission No. of Admissions (000s) Source: The DASIS Report, Treatment Admissions Involving Narcotic Painkillers: 2002 Update

Current Use of Prescription Drugs for Nonmedical Purposes in StimulantsSedatives and Tranquilizers Pain Relievers Millions of Americans Source: Office of Applied Studies, Substance Abuse and Mental Health Services Administration, National Household Survey on Drug Abuse, 1999

Promotional Spending for Three Opioid Analgesics in First 6 Years of Sales Year 1Year 2Year 3Year 4Year 5Year 6 Absolute Dollars in Millions, 2002 Adjusted MS Contin: OxyContin: Duragesic: Source: United States GAO Report to Congressional Requesters, Oxytocin Abuse and Diversion and Efforts to Address the Problem

Estimated numbers (in thousands) and percentages of persons reporting past year use of, past year abuse of, or dependence on opioids and tranquilizers NumberPercent (pop) Percent (users) Percent (pop) Percent (users) Opioids Tranquilizers Past year usersPast year abuse or dependence Past year dependence Source: J. Zacny et al, Drug and Alcohol Dependence 69, (2003)

Terminology “Substance Abuse” used broadly Any useSubstance use disorders DSM-IV Dependence Any 3 of: tolerance withdrawal uses more or longer than intended unable to cut down use consumes a great deal of time important social/work activities given up continued use despite psychological or physical problems known to be caused by substance DSM-IV Abuse Any 1 of: recurrent use causing failure to fulfill major role obligations at work/home/school recurrent use when physically hazardous recurrent substance-related legal problems continued use despite persistent social/interpersonal problems due to substance use

Prescription Opioid Abuse/Dependence we do not know the prevalence of prescription opioid use disorders nor the characteristics or life circumstances of the individuals that develop these disorders we know very little about how regular opioid use evolves into problematic use and substance use disorders

Study 1. Interviews with Oral Opioid Dependent Inpatients Objectives: To determine the characteristics, patterns of drug use, treatment and outcome of patients severely dependent on oral opioids Subjects: 58 patients (60% male, mean age 35.4  9.5 years) admitted to the inpatient Medical Unit of the Addiction Research Foundation Methods: Data collected prospectively by structured interview using the psychoactive substance use module of the Structured Clinical Interview for DSM- III-R (SCID). Busto UE, Sproule BA, Knight K, Romach MK, Sellers EM. Severe dependence on oral opiates. The Canadian Journal of Clinical Pharmacology 1998;5(1):23-28.

Demographic characteristics of severely opioid-dependent patients (N=58) number% SexMale Female Admission age (yrs) Mean age (  SD)  EducationPublic school or lower Some secondary school Secondary school completed Post secondary school incomplete Post secondary school completed Source: U. Busto et al, Can J Clin Pharmacol Vol 5 No 1 (1998) 23-28

Percentage of Patients with aCurrent Substance Use Disorder other than Opioid Substance Use Disorder AlcoholSedative-HypnoticCannabisStimulant Percentage of Patients Abuse Dependence Percentage of Patients with aPast Substance Use Disorder other than Opioid Substance Use Disorder AlcoholSedative-HypnoticCannabisStimulant Percentage of Patients Source: U. Busto et al, Can J Clin Pharmacol Vol 5 No 1 (1998) 23-28

Combinations of Current Psychoactive Substance Use Disorders Opioid only (34%) Opioid and one other (2%) Opioid and Alcohol (9%) Opioid and Sedative- Hypnotics (19%) Alcohol, Sedative-Hypnotics, Cannabis, Cocaine, Polydrug Hallucinogens, Stimulants Opioid and at least 2 others (36%): Source: U. Busto et al, Can J Clin Pharmacol Vol 5 No 1 (1998) 23-28

Proportion of Opioid-Dependent Patients Meeting DSM-III-R Criteria for Current Opioid Dependence All 9 Criteria 7 Criteria 6 Criteria 3-5 Criteria Withdrawal Symptoms, Marked Tolerance, Inability to Stop, Persistent Use, Use in Spite of Problems, Withdrawal Relief, Hazardous Use, Much Time Spent Getting Substance, Use Interferes with Activities 8 Criteria Source: U. Busto et al, Can J Clin Pharmacol Vol 5 No 1 (1998) 23-28

Study 1 cont’d Results: mean daily dose of codeine: 554  343 mg (range 120mg to 1500mg) mean daily oxycodone dose (in codeine equivalents): 1265  1377 mg, range 333 to 6670 mg, p<0.01) 36% also met criteria for abuse or dependence on at least 2 other substances mean duration of opioid use at the current dose: 7 years majority obtained opioids by going to different physicians (39%), although 26% got their opioids primarily from one physician 26% purchased oral opioids off the street Busto UE, Sproule BA, Knight K, Romach MK, Sellers EM. Severe dependence on oral opiates. The Canadian Journal of Clinical Pharmacology 1998;5(1):23-28.

Study 2 - Survey of Regular Users of Codeine Objectives: to determine the characteristics of a broader population of regular opioid users Subjects: n=339 individuals who were using codeine at least 3 days per week for the past 6 months (excluding cancer pain patients); 49% males, mean age 43 ± 12 years Methods: anonymous 27 page questionnaire assessment of codeine dependence and abuse in the past year was made on the basis of written short answers to open-ended questions two trained investigators evaluated the responses to determine whether the criteria were clearly met, clearly not met, or whether it could not be determined on the basis of the information provided

Study 2 cont’d Results: currently using acetaminophen with codeine products (30mg 37%, 8mg 23%) mean daily dose of 115mg (range mg) at least 5-6 days per week (70%) used an average of 12 ± 9 years 37% (n=124) met DSM-IV criteria for codeine dependence 30% identified themselves with problematic codeine use most obtained codeine from one physician (66%) most (81%) reported chronic pain (55% headaches) Sproule BA, Busto UE, Somer G, Romach MK, Sellers EM. Characteristics of dependent and non-dependent regular users of codeine. Journal of Clinical Psychopharmacology 1999;19(4):

DSM-IV Criteria in Dependent Group %

Most Common Psychological and Physical Problems Associated with Codeine Use %

Study 2 cont’d dependent subjects currently found codeine less effective for treating pain only 42% of the dependent subjects with chronic pain had tried non-opioid medication for their pain dependent subjects were more likely to use codeine for pleasurable effects, to relax, or to prevent withdrawal symptoms subjects in the dependent group also obtained their codeine from friends (32%), from family (11%), off the street (19%), and through prescriptions from more than one doctor (11%) Sproule BA, Busto UE, Somer G, Romach MK, Sellers EM. Characteristics of dependent and non-dependent regular users of codeine. Journal of Clinical Psychopharmacology 1999;19(4):

Dependent vs Non-Dependent Subjects DependentNon-Dependent Mean Daily Dose176 mg74mg Alcohol Problems57%26% Cannabis Problems23%5% Sought help for mental health problem 76%55% Psychiatric hospitalization22%8%

Study 2 cont’d Conclusions: chronic codeine use is associated with dependence, as well as substantial comorbid pain and psychiatric problems Sproule BA, Busto UE, Somer G, Romach MK, Sellers EM. Characteristics of dependent and non-dependent regular users of codeine. Journal of Clinical Psychopharmacology 1999;19(4):

Study 3. Retrospective Study of Prescription Opioid Use in Methadone Maintenance Patients steep increase in the number of patients dependent on prescription opioids admitted to our methadone maintenance treatment program following an expansion in service in the latter half of the 1990s in Ontario detailed retrospective chart review of patients admitted to methadone maintenance treatment after program expansion was conducted n=178, mean age=34.5±0.7 years, 65% male at admission most patients (82%) had been using prescription opioids (± heroin)

Drug use history for three chronological patient cohorts at the time of admission to MMT Cohort 1Cohort 2Cohort 3p value % Currently injecting drugs Hepatitis C seroprevalence: % positive Source: B. Brands et al, Drug and Alcohol Dependence 66, (2002) 11-20

Cumulative 2-Year Retention in the CAMH MMT Program for 3 Chronological Patient Cohorts Treatment Duration (months) Cumulative Program Retention Cohort 1 (n=63) Cohort 2 (n=95) Cohort 3 (n=82) Source: B. Brands et al, Drug and Alcohol Dependence 66, (2002) 11-20

Overall Summary Points Prescription opioid abuse/dependence has not been well studied. There are indicators that this may be an increasing problem. Severe dependence on oral opioids is possible, and is likely to be associated with polysubstance abuse and treatment relapse. Regular codeine use is associated with substantial dependence, although the exact prevalence is not known. Psychiatric comorbidity is very common. Pain was not optimally treated in these patients. Prescription opioid dependent has increased among patients admitted to our methadone maintenance treatment program, again with indications of significant psychiatric comorbidity in this population.

Prescription Opioid Abuse and Dependence Acknowledgements Dr. M. RomachMs. J. Blake Dr. E. M. SellersDr. D. Gourlay Ms. K. KnightMs. G. Somer Mr. A. MacDonaldMs. H. Kameh Funding: CAMH, OMHF